adminplenoptika stock
Financial Conflict of Interest Policy PlenOptika
Financial Conflict of Interest Policy PlenOptika, Inc. Financial Conflict of Interest Policy Last Update: December 01, 2020 (Revision A) Policy Overview: The performance of research in an objective and fair manner is a core value of PlenOptika, Inc. (PlenOptika). It is expected that members of the PlenOptika research team (“Investigators”), its subgrantees, clinical research partners, and
PlenOptika engineer named 2020 IAPB Eye Health Hero
PlenOptika is a Valued Supplier on the IAPB Standard List, and the technology powering QuickSee was developed in the international collaboration the MadridMIT M+Visión Consortium, with
QuickSee handheld autorefractor can dramatically increase
PlenOptika, the maker of QuickSee, assisted in study design but its execution, analysis, and reporting were independent of the company. The stock market started September with mixed
QuickSee handheld autorefractor can dramatically increase
PlenOptika designs and produces tools to help vision professionals perform their best care anywhere. Inspired to solve the global burden of poor vision, we developed QuickSee, the world''s most
How to Buy, QuickSee Handheld Autorefractor, from
Get Quicksee We welcome the chance to answer your questions—we’re confident it’s a great tool for your vision care practice, in the clinic or anywhere else you take it. Please fill in this form and we’ll be in touch within 24 hours. Special pricing during the COVID19 pandemic. Contact us for details.
Solving the global glasses gap. Roughly two billion people
PlenOptika has gotten this far with just under $2 million in grant funding over the past five and a half years. In that time, a number of other lowcost vision care products have emerged, both
PlenOptika engineer named 2020 IAPB Eye Health Hero
BOSTON, Oct. 5, 2020 /PRNewswire/ PlenOptika, a biomedical technology company bringing cuttingedge vision technology to frontline vision
QuickSee Handheld Autorefractor Shows Strong
The paper “Validation of an Affordable Handheld Wavefront Autorefractor,“published in the journal Optometry and Vision Science, shows visual acuity improvement resulting from correction based on QuickSee measurements was the same as that achieved by subjective refraction in 87% of the eyes tested.This is comparable to results reported for clinically established benchtop systems and exceeds